All Stories

  1. Implementation is the key to success
  2. A Survey of Open Science Attitudes and Behaviors among US Pharmacy Faculty
  3. Before you click submit: Double check your manuscript
  4. Pharmacy in 2050: To succeed, we must adapt
  5. A Survey of Open Science Attitudes and Behaviors among US Pharmacy Faculty
  6. Rising to the challenge: Advancing the profession through science and research
  7. Considerations for writing and including demographic variables in education research
  8. Meta-research in pharmacy: Time for a look in the mirror
  9. Setting the pace for best practices in reporting pharmacist care interventions: The PaCIR checklist
  10. Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment
  11. Evaluating a measure of the research training environment in a sample of pharmacy residents
  12. Developing a Measure of Students’ Potential Involvement in Scholarly Activities
  13. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature
  14. The Impact of Integrated Case Management on Health Services Use and Spending Among Nonelderly Adult Medicaid Enrollees
  15. How to analyze Likert and other rating scale data
  16. Announcing a new section—Methodology Matters
  17. The Choice of Analytical Strategies in Inverse-Probability-of-Treatment–Weighted Analysis: A Simulation Study
  18. Risk of Fracture and the Concomitant Use of Bisphosphonates With Osteoporosis-Inducing Medications
  19. Being open to missed opportunities
  20. Homeless Patientsʼ Use of Urban Emergency Departments in the United States
  21. Response to “Modifications to the Drug Burden Index Calculation May Limit Interpretation of Its Association With Clinical Outcomes In Older Adults”(doi:10.1007/s12028-014-0006-8)
  22. Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump inhibitors
  23. Potentially Inappropriate Medication Use is Associated with Clinical Outcomes in Critically Ill Elderly Patients with Neurological Injury
  24. Effect of Renin–Angiotensin System Inhibition on Cardiovascular Events in Older Hypertensive Patients with Metabolic Syndrome
  25. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres
  26. The Importance of Study Design When Comparing Baseline Characteristics between Study Groups
  27. An Active-Learning Laboratory on Immunizations
  28. Warfarin–Antibiotic Interactions in Older Adults of an Outpatient Anticoagulation Clinic
  29. Effects of a learning-centered approach to assessment on students' attitudes towards and knowledge of statistics
  30. Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship
  31. Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial Stewardship
  32. Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals
  33. Warfarin Use in Nursing Home Residents: Results from the 2004 National Nursing Home Survey
  34. An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States
  35. Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study
  36. Economic Impact ofClostridium difficileInfection in a Multihospital Cohort of Academic Health Centers
  37. A Pharmacoepidemiologic Analysis of the Impact of Calendar Packaging on Adherence to Self-Administered Medications for Long-Term Use
  38. Increase in Use of Vancomycin for Clostridium difficile Infection in US Hospitals
  39. Use of International Classification of Diseases, Ninth Revision Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
  40. Using Secondary Data Sources for Pharmacoepidemiology and Outcomes Research
  41. Testing for allergic disease: Parameters considered and test value
  42. Diversity of Antimicrobial Use and Resistance in 42 Hospitals in the United States
  43. The Relative Importance of Health Related Quality of Life and Prescription Insurance Coverage in the Decision to Pharmacologically Manage Symptoms of Overactive Bladder
  44. Comparison of Darbepoetin alfa and Epoetin alfa in the Management of Anemia of Critical Illness
  45. Improving the safety of medication administration using an interactive CD-ROM program